-
1دورية أكاديمية
المؤلفون: Mattias F. Lindberg, Emmanuel Deau, Frédéric Miege, Marie Greverie, Didier Roche, Nicolas George, Pascal George, Laura Merlet, Julie Gavard, Sander J. T. Brugman, Edwin Aret, Paul Tinnemans, René de Gelder, Jan Sadownik, Eva Verhofstad, Dennis Sleegers, Sara Santangelo, Julien Dairou, Álvaro Fernandez-Blanco, Mara Dierssen, Andreas Krämer, Stefan Knapp, Laurent Meijer
مصطلحات موضوعية: Biochemistry, Medicine, Pharmacology, Biotechnology, Computational Biology, Chemical Sciences not elsewhere classified, residence time assays, ray powder diffraction, differential scanning calorimetry, direct catalytic activity, 21 inhibits dyrk1a, activity studies, tyrosine phosphorylation, thermal shift, therapeutic target, tau ), targets ”, substituted 2, reveals dyrk1a, physiological characterization, physicochemical properties, phosphorylation levels, pharmacological inhibitors, multiparametric evaluations, may contribute, like profile, first target, entering safety, dyrk1a structure, cyclin d1
الإتاحة: https://doi.org/10.1021/acs.jmedchem.3c01888.s001Test
https://figshare.com/articles/journal_contribution/Chemical_Biochemical_Cellular_and_Physiological_Characterization_of_Leucettinib-21_a_Down_Syndrome_and_Alzheimer_s_Disease_Drug_Candidate/24747737Test -
2
المؤلفون: Mattias F. Lindberg, Emmanuel Deau, Frédéric Miege, Marie Greverie, Didier Roche, Nicolas George, Pascal George, Laura Merlet, Julie Gavard, Sander J. T. Brugman, Edwin Aret, Paul Tinnemans, René de Gelder, Jan Sadownik, Eva Verhofstad, Dennis Sleegers, Sara Santangelo, Julien Dairou, Álvaro Fernandez-Blanco, Mara Dierssen, Andreas Krämer, Stefan Knapp, Laurent Meijer
مصطلحات موضوعية: Biochemistry, Medicine, Pharmacology, Biotechnology, Computational Biology, Chemical Sciences not elsewhere classified, residence time assays, ray powder diffraction, differential scanning calorimetry, direct catalytic activity, 21 inhibits dyrk1a, activity studies, tyrosine phosphorylation, thermal shift, therapeutic target, tau ), targets ”, substituted 2, reveals dyrk1a, physiological characterization, physicochemical properties, phosphorylation levels, pharmacological inhibitors, multiparametric evaluations, may contribute, like profile, first target, entering safety, dyrk1a structure, cyclin d1
الإتاحة: https://doi.org/10.1021/acs.jmedchem.3c01888.s002Test
https://figshare.com/articles/dataset/Chemical_Biochemical_Cellular_and_Physiological_Characterization_of_Leucettinib-21_a_Down_Syndrome_and_Alzheimer_s_Disease_Drug_Candidate/24747740Test